TY  - JOUR

T1  - Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - PharmacoEconomics

UR  - http://eprints.whiterose.ac.uk/114663/

PY  - 2017/05/01

AU  - Carroll C

AU  - Tappenden P

AU  - Rafia R

AU  - Hamilton J

AU  - Chambers D

AU  - Clowes M

AU  - Durrington P

AU  - Qureshi N

AU  - Wierzbicki AS

ED  - 

DO  - DOI: 10.1007/s40273-017-0492-6

VL  - 35

IS  - 5

SP  - 537

EP  - 547

Y2  - 2024/12/21

ER  -